THE US Food and Drug Administration has approved Noctiva (desmospressin acetate) nasal spray for adults who awaken at least twice per night to urinate.
The medication treats a condition known as nocturnal polyuria (overproduction of urine during the night), and Noctiva is the first FDA-approved treatment for the condition.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Mar 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Mar 17
